JP Morgan maintains 'Overweight' rating on LIC post Q4 results, setting target price of Rs 1,340. LIC's market share growth and strong earnings drive stock performance.
, the global brokerage firm, has upheld its 'Overweight' rating on following the announcement of its at a of Rs 1,340. This projection suggests a potential increase of 29% from the previous day's closing price of Rs 1,035.8 per share.In its report, JP Morgan highlighted LIC's strong performance in Q4, particularly noting its impressive earnings and surpassing (NBV) expectations.
The global investment bank commends LIC's strategic focus on growth over profitability, with market observers acknowledging the company's expanding as a significant driver for its stock performance.
Furthermore, JP Morgan emphasised, "The stock appears undervalued, with ample room for robust ."
Also Read:
Meanwhile, India's leading life insurer disclosed a of Rs 13,782 crore for the quarter ending March 31, 2024, marking a 4.5% rise compared to Rs 13,191 crore reported in the corresponding period of the previous fiscal year.
Maintaining its dominance in the Indian life insurance sector, commands an impressive 58.87% market share in (FYPI). Notably, for the fiscal year ending March 31, 2024, LIC's market share reached 38.44% in individual business and 72.30% in group business.
The Total Premium Income for the fiscal year ending March 31, 2024, amounted to Rs 4,75,070 crore, marginally higher than the Rs 4,74,005 crore reported in the previous fiscal year. Meanwhile, the Total Individual Business Premium for the same period increased to Rs 3,03,768 crore from Rs 2,92,763 crore in the corresponding period of the previous year.
LIC's (VNB) for the fiscal year ending March 31, 2024, stood at Rs 9,583 crore, exhibiting a growth of 4.66% compared to Rs 9,156 crore reported in the previous fiscal year. Moreover, the net VNB margin for the fiscal year ending March 31, 2024, saw a notable increase of 60 basis points to 16.80% from 16.20% in the previous fiscal year.
At 11:21 am, the scrip was trading 0.5% lower at Rs 1,030 on BSE. The stock has rallied 52.8% in the last six months, compared to a 14.15% gain in the Sensex.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Source: Stocks-Markets-Economic Times